Journal rankings · indicator year 2025
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2025
Medicine journal rankings 2025
4,521 ranked journals · Field in Health Sciences
Medicine has 4,521 ranked journals in 2025. The median journal has an OJR of 0.67, below the world average of 1.00, up 0.01 on 2024; Q1 starts at OJR 1.08. The three highest-scoring journals with stable ranks are CA A Cancer Journal for Clinicians, New England Journal of Medicine, and Nature Reviews Disease Primers: each is likely ranked within the top 46.
Ranks and citation indicators: 2025. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2022–2024, the window the 2025 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Medicine (42)
Up to Health Sciences- Surgery945
- Pulmonary and Respiratory Medicine352
- Public Health, Environmental and Occupational Health311
- Cardiology and Cardiovascular Medicine287
- Infectious Diseases258
- Oncology242
- Epidemiology178
- Neurology168
- Radiology, Nuclear Medicine and Imaging160
- Physiology154
- Endocrinology, Diabetes and Metabolism152
- Psychiatry and Mental health139
Show all 42 subfields
- Orthopedics and Sports Medicine121
- Ophthalmology96
- Pediatrics, Perinatology and Child Health95
- Dermatology89
- Obstetrics and Gynecology81
- Hematology78
- Rheumatology70
- Nephrology62
- Complementary and alternative medicine58
- Reproductive Medicine53
- Pharmacology49
- Emergency Medicine44
- Geriatrics and Gerontology38
- Otorhinolaryngology32
- Rehabilitation31
- Pathology and Forensic Medicine29
- Hepatology28
- Immunology and Allergy25
- Critical Care and Intensive Care Medicine24
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology13
- Health Informatics10
- Gastroenterology6
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
4,521 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. The small range under it is the likely rank range: in 95% of 1,000 resamples of the journal’s papers, it ranked inside that range. Journals whose ranges overlap are not clearly different. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2024. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2022–2024, the window the 2025 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2022–2024 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2016 to 2025. A label compares the 2022→2025 change with the median change of the journal’s field or domain. Rising needs a relative change of +10% or more that is at least 2 standard errors above zero; Falling needs -9.1% or less (rounded), at least 2 standard errors below zero. Sorting uses that relative change. | Compare |
|---|---|---|---|---|---|---|---|
Rank 1; likely between #1 and #1 of 4,521CA A Cancer Journal for CliniciansOAWiley · United States | 116.27Q1 | 505.84 229.09 up from 2024 | 78 | 100% | $4,330 | ||
Rank 2; likely between #2 and #4 of 4,521New England Journal of MedicineMassachusetts Medical Society · United States | 12.85Q1 | 34.58 2.47 up from 2024 | 2,504 | 16% | — | ||
Rank 3; likely between #2 and #5 of 4,521Nature Reviews Disease PrimersNature Portfolio · United Kingdom | 12.51Q1 | 72.06 17.61 up from 2024 | 134 | 17% | — | ||
Rank 4; likely between #2 and #8 of 4,521Endocrine ReviewsOxford University Press · United States | 10.95Q1 | 26.30 0.11 down from 2024 | 97 | 75% | $3,750 | ||
Rank 5; likely between #3 and #6 of 4,521Nature MedicineNature Portfolio · United States | 10.80Q1 | 33.21 0.42 up from 2024 | 1,446 | 55% | $12,690 | ||
Rank 6; likely between #4 and #9 of 4,521Journal of Hematology & OncologyOABioMed Central · United Kingdom | 9.48Q1 | 32.16 1.95 up from 2024 | 397 | 100% | $4,990 | Rising vs field, 2022–25 | |
Rank 7; likely between #5 and #11 of 4,521Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 9.01Q1 | 21.99 0.70 down from 2024 | 108 | 100% | — | ||
Rank 8; likely between #5 and #11 of 4,521Cancer CellCell Press · Netherlands | 8.99Q1 | 38.39 10.90 up from 2024 | 541 | 57% | $10,400 | Rising vs field, 2022–25 | |
Rank 9; likely between #5 and #12 of 4,521CirculationLippincott Williams & Wilkins · United States | 8.59Q1 | 25.08 2.29 up from 2024 | 1,319 | 5% | — | Rising vs field, 2022–25 | |
Rank 10; likely between #7 and #21 of 4,521The Lancet NeurologyElsevier BV · Netherlands | 7.33Q1 | 19.32 1.22 up from 2024 | 622 | 33% | $7,280 | ||
Rank 11; likely between #9 and #20 of 4,521Nature Reviews Clinical OncologyNature Portfolio · United Kingdom | 7.20Q1 | 36.39 4.12 up from 2024 | 368 | 12% | — | Rising vs field, 2022–25 | |
Rank 12; likely between #10 and #16 of 4,521Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 7.00Q1 | 19.67 0.55 down from 2024 | 1,511 | 47% | — | ||
Rank 13; likely between #10 and #25 of 4,521The Lancet Diabetes & EndocrinologyElsevier BV · Netherlands | 6.57Q1 | 14.49 3.74 down from 2024 | 460 | 39% | $7,280 | ||
Rank 14; likely between #12 and #26 of 4,521The Lancet OncologyElsevier BV · United Kingdom | 6.16Q1 | 18.11 0.35 up from 2024 | 865 | 23% | $7,280 | ||
Rank 15; likely between #11 and #34 of 4,521The Lancet. Gastroenterology & hepatologyElsevier BV · United Kingdom | 6.09Q1 | 15.18 2.28 down from 2024 | 546 | 34% | $7,280 | Rising vs field, 2022–25 | |
Rank 16; likely between #13 and #28 of 4,521MMWR Morbidity and Mortality Weekly ReportOACenters for Disease Control and Prevention · United States | 5.97Q1 | 16.46 1.77 down from 2024 | 713 | 100% | — | Falling vs field, 2022–25 | |
Rank 17; likely between #12 and #35 of 4,521Progress in Retinal and Eye ResearchElsevier BV · Netherlands | 5.94Q1 | 16.65 1.64 up from 2024 | 126 | 67% | $6,710 | ||
Rank 18; likely between #12 and #34 of 4,521Journal of HepatologyElsevier BV · Denmark | 5.88Q1 | 18.77 2.17 up from 2024 | 1,172 | 10% | $5,500 | ||
Rank 19; likely between #9 and #47 of 4,521Cancer DiscoveryAmerican Association for Cancer Research · United States | 5.80Q1 | 16.92 6.58 down from 2024 | 543 | 30% | — | ||
Rank 20; likely between #14 and #31 of 4,521Journal of the American College of CardiologyElsevier BV · United States | 5.77Q1 | 13.27 1.07 down from 2024 | 1,603 | 79% | $7,166 | ||
Rank 21; likely between #11 and #51 of 4,521Current Obesity ReportsSpringer Science+Business Media · United States | 5.64Q1 | 18.43 5.00 up from 2024 | 120 | 62% | $5,790 | Rising vs field, 2022–25 | |
Rank 22; likely between #15 and #43 of 4,521Translational NeurodegenerationOABioMed Central · China | 5.46Q1 | 16.98 0.58 up from 2024 | 175 | 100% | $2,990 | Rising vs field, 2022–25 | |
Rank 23; likely between #16 and #41 of 4,521Molecular NeurodegenerationOABioMed Central · United Kingdom | 5.43Q1 | 18.00 1.60 up from 2024 | 255 | 100% | $3,090 | ||
Rank 24; likely between #13 and #50 of 4,521European Heart JournalOxford University Press · United Kingdom | 5.35Q1 | 15.89 2.06 up from 2024 | 2,108 | 13% | $5,922 | ||
Rank 25; likely between #15 and #45 of 4,521Diabetes CareAmerican Diabetes Association · United States | 5.34Q1 | 16.28 2.29 up from 2024 | 1,270 | 86% | — | ||
Rank 26; likely between #7 and #187 of 4,521Journal of Medicine Surgery and Public HealthOAElsevier BV | 5.29Q1 | 14.25 12.25 up from 2024 | 167 | 100% | $1,900 | ||
Rank 27; likely between #19 and #46 of 4,521Medical Image AnalysisElsevier BV · United Kingdom | 5.15Q1 | 17.25 1.42 up from 2024 | 845 | 47% | $4,170 | Rising vs field, 2022–25 | |
Rank 28; likely between #19 and #45 of 4,521The Lancet Digital HealthOAElsevier BV · United Kingdom | 5.13Q1 | 18.66 1.39 down from 2024 | 351 | 100% | $6,680 | ||
Rank 29; likely between #16 and #48 of 4,521GutBMJ · United Kingdom | 5.11Q1 | 13.54 2.14 down from 2024 | 821 | 47% | — | ||
Rank 30; likely between #4 and #443 of 4,521Journal of the National Cancer CenterOAElsevier BV · China | 5.06Q1 | 18.92 10.03 up from 2024 | 129 | 100% | $2,160 | ||
Rank 31; likely between #16 and #55 of 4,521European UrologyElsevier BV · Switzerland | 5.04Q1 | 15.82 2.42 up from 2024 | 559 | 15% | $5,250 | ||
Rank 32; likely between #22 and #43 of 4,521npj Digital MedicineOANature Portfolio · United States | 5.03Q1 | 21.65 3.13 up from 2024 | 786 | 100% | $4,090 | ||
Rank 33; likely between #20 and #50 of 4,521AutophagyTaylor & Francis · United States | 4.89Q1 | 16.03 3.40 up from 2024 | 499 | 99% | — | ||
Rank 34; likely between #17 and #61 of 4,521Journal of the National Comprehensive Cancer NetworkNational Comprehensive Cancer | 4.88Q1 | 13.42 0.76 down from 2024 | 561 | 20% | — | ||
Rank 35; likely between #23 and #50 of 4,521Nature CancerNature Portfolio · United States | 4.84Q1 | 16.64 2.22 down from 2024 | 468 | 41% | $12,690 | Rising vs field, 2022–25 | |
Rank 36; likely between #17 and #61 of 4,521HepatologyLippincott Williams & Wilkins · United States | 4.82Q1 | 16.27 1.50 up from 2024 | 988 | 26% | $2,900 | Rising vs field, 2022–25 | |
Rank 37; likely between #24 and #50 of 4,521JAMA NeurologyAmerican Medical Association · United States | 4.79Q1 | 12.37 0.54 up from 2024 | 684 | 52% | — | ||
Rank 38; likely between #24 and #51 of 4,521Seminars in Cancer BiologyElsevier BV · United States | 4.77Q1 | 18.57 1.72 up from 2024 | 295 | 30% | $6,060 | Rising vs field, 2022–25 | |
Rank 39; likely between #24 and #53 of 4,521The Lancet Respiratory MedicineElsevier BV · Netherlands | 4.76Q1 | 13.34 0.70 down from 2024 | 535 | 42% | $7,280 | ||
Rank 40; likely between #25 and #52 of 4,521DrugsAdis, Springer Healthcare · New Zealand | 4.72Q1 | 14.94 0.72 down from 2024 | 395 | 40% | $5,990 | Rising vs field, 2022–25 | |
Rank 41; likely between #26 and #59 of 4,521The Lancet Global HealthOAElsevier BV · Netherlands | 4.51Q1 | 10.46 1.30 up from 2024 | 998 | 100% | $6,680 | ||
Rank 42; likely between #9 and #306 of 4,521Meta-RadiologyOAElsevier BV | 4.43Q1 | 18.23 7.81 down from 2024 | 52 | 100% | $0 listed | ||
Rank 43; likely between #34 and #55 of 4,521Cardiovascular DiabetologyOABioMed Central · United Kingdom | 4.39Q1 | 15.86 4.29 up from 2024 | 1,073 | 100% | $4,290 | Rising vs field, 2022–25 | |
Rank 44; likely between #24 and #66 of 4,521MetabolismElsevier BV · United States | 4.38Q1 | 16.10 3.92 up from 2024 | 422 | 37% | $5,340 | Rising vs field, 2022–25 | |
Rank 45; likely between #25 and #73 of 4,521Human Reproduction UpdateOxford University Press · United Kingdom | 4.35Q1 | 19.77 1.61 up from 2024 | 108 | 72% | $4,490 | Rising vs field, 2022–25 | |
Rank 46; likely between #28 and #69 of 4,521Nature Reviews Gastroenterology & HepatologyNature Portfolio · United Kingdom | 4.35Q1 | 20.05 1.39 up from 2024 | 432 | 17% | — | ||
Rank 47; likely between #31 and #62 of 4,521The Lancet Infectious DiseasesElsevier BV · Netherlands | 4.32Q1 | 12.62 0.02 down from 2024 | 1,035 | 36% | $7,280 | ||
Rank 48; likely between #13 and #159 of 4,521The Lancet RheumatologyElsevier BV · United Kingdom | 4.22Q1 | 14.50 6.12 up from 2024 | 399 | 29% | $7,280 | Rising vs field, 2022–25 | |
Rank 49; likely between #35 and #76 of 4,521Nature Reviews CardiologyNature Portfolio · United Kingdom | 4.13Q1 | 19.21 3.54 up from 2024 | 422 | 23% | — | ||
Rank 50; likely between #24 and #117 of 4,521npj AgingSpringer Science+Business Media | 4.07Q1 | 14.08 7.34 up from 2024 | 100 | 100% | $3,690 |
404 Medicine journals are labelled rising: their OJR moved up between 2022 and 2025 clearly faster than the median journal of their field or domain.
A journal is rising when its OJR grew from 2022 to 2025 faster than the median journal of its field (or domain, when the field is small), by two tests: the relative change is +10% or more, and it is at least 2 standard errors above zero. So the range of the change at 2 standard errors stays above zero, though not necessarily above +10%.
The bar is that range on a ratio scale; the shaded band, -9.1% to +10%, holds changes too small for a label. The list is ordered by the low end of the range, so the surest rises come first.
- 1Journal of the Pediatric Orthopaedic Society of North AmericaOASurgery+326% vs groupOJR 0.11 → 0.44range +189% to +527%
- 2HIV/AIDS - Research and Palliative CareOAInfectious Diseases+235% vs groupOJR 0.35 → 1.09range +166% to +322%
- 3Structural HeartOACardiology and Cardiovascular Medicine+255% vs groupOJR 0.29 → 0.96range +160% to +384%
- 4Clinical and Experimental Obstetrics & GynecologyOAObstetrics and Gynecology+231% vs groupOJR 0.11 → 0.33range +151% to +338%
- 5Access MicrobiologyOAInfectious Diseases+183% vs groupOJR 0.19 → 0.50range +126% to +254%
- 6Daehan nae'si'gyeong bog'gang'gyeong oe'gwa haghoeji/Journal of minimally invasive surgeryOASurgery+330% vs groupOJR 0.14 → 0.57range +125% to +722%
- 7Public Health ActionOAInfectious Diseases+220% vs groupOJR 0.27 → 0.79range +120% to +365%
- 8Neurosurgical Focus VideoOANeurology+212% vs groupOJR 0.11 → 0.32range +109% to +365%
- 9Translational Cancer ResearchOAPulmonary and Respiratory Medicine+124% vs groupOJR 0.25 → 0.51range +102% to +149%
- 10Journal of Translational Internal MedicinePulmonary and Respiratory Medicine+168% vs groupOJR 0.99 → 2.48range +101% to +256%
- 11Advances in respiratory medicineOAPulmonary and Respiratory Medicine+212% vs groupOJR 0.40 → 1.16range +100% to +389%
- 12Journal of ISAKOS Joint Disorders & Orthopaedic Sports MedicineOASurgery+172% vs groupOJR 0.57 → 1.45range +99% to +273%
- 13AIDS Research and TherapyOAInfectious Diseases+154% vs groupOJR 0.55 → 1.31range +98% to +226%
- 14Annals of MedicineOASurgery+123% vs groupOJR 0.85 → 1.78range +88% to +165%
- 15Journal of Clinical AnesthesiaSurgery+120% vs groupOJR 0.79 → 1.62range +86% to +160%
- 16The Korean Journal of Thoracic and Cardiovascular SurgeryOASurgery+141% vs groupOJR 0.24 → 0.54range +81% to +221%
- 17Journal of the International AIDS SocietyOAInfectious Diseases+106% vs groupOJR 0.89 → 1.71range +78% to +138%
- 18AIDS CareInfectious Diseases+102% vs groupOJR 0.37 → 0.70range +74% to +135%
- 19Journal of the International Association of Providers of AIDS Care (JIAPAC)OAInfectious Diseases+149% vs groupOJR 0.51 → 1.19range +73% to +259%
- 20Journal of Global Health ReportsOAPediatrics, Perinatology and Child Health+133% vs groupOJR 0.33 → 0.71range +68% to +223%
No-label zone, -9.1% to +10%Group median changeBar scale -89% to +813% (ratio scale)
390 Medicine journals are labelled falling: their OJR moved between 2022 and 2025 clearly behind the median journal of their field or domain.
A journal is falling when its OJR changed from 2022 to 2025 by less than the median journal of its field (or domain, when the field is small), by two tests: the relative change is -9.1% or less (rounded), and it is at least 2 standard errors below zero. So the range of the change at 2 standard errors stays below zero, though not necessarily below -9.1%.
The bar is that range on a ratio scale; the shaded band, -9.1% to +10%, holds changes too small for a label. The list is ordered by the high end of the range, so the surest falls come first.
- 1SN Comprehensive Clinical MedicineSurgery-69% vs groupOJR 0.72 → 0.21range -80% to -51%
- 2Journal of Radiology Case ReportsOASurgery-69% vs groupOJR 0.70 → 0.20range -81% to -50%
- 3Topics in Spinal Cord Injury RehabilitationPathology and Forensic Medicine-64% vs groupOJR 1.55 → 0.52range -76% to -48%
- 4Pharmacy PracticeOAGeriatrics and Gerontology-63% vs groupOJR 1.09 → 0.38range -74% to -47%
- 5Telemedicine Journal and e-HealthPublic Health, Environmental and Occupational Health-55% vs groupOJR 2.23 → 0.93range -64% to -46%
- 6Revista Brasileira de Medicina do EsporteOrthopedics and Sports Medicine-56% vs groupOJR 0.52 → 0.22range -66% to -42%
- 7Open Access Macedonian Journal of Medical SciencesOAPediatrics, Perinatology and Child Health-46% vs groupOJR 0.36 → 0.18range -52% to -40%
- 8Journal of Cystic FibrosisPulmonary and Respiratory Medicine-50% vs groupOJR 1.20 → 0.56range -59% to -39%
- 9Current Medicine Research and PracticeOAPublic Health, Environmental and Occupational Health-78% vs groupOJR 0.74 → 0.15range -93% to -35%
- 10Revista do Colégio Brasileiro de CirurgiõesOASurgery-53% vs groupOJR 0.73 → 0.32range -66% to -34%
- 11Asian Bioethics ReviewPublic Health, Environmental and Occupational Health-55% vs groupOJR 1.93 → 0.82range -69% to -33%
- 12Brazilian Journal of NephrologyOANephrology-55% vs groupOJR 0.61 → 0.26range -70% to -33%
- 13Dermatology Online JournalOADermatology-48% vs groupOJR 0.46 → 0.23range -59% to -33%
- 14Photobiomodulation Photomedicine and Laser SurgeryRadiology, Nuclear Medicine and Imaging-46% vs groupOJR 0.93 → 0.47range -56% to -32%
- 15MedicinesOAPhysiology-50% vs groupOJR 1.55 → 0.72range -64% to -32%
- 16Journal of ColoproctologyOASurgery-59% vs groupOJR 0.29 → 0.11range -76% to -32%
- 17Academic PsychiatryPublic Health, Environmental and Occupational Health-48% vs groupOJR 0.84 → 0.41range -60% to -32%
- 18Cardiology ClinicsCardiology and Cardiovascular Medicine-50% vs groupOJR 1.21 → 0.57range -64% to -31%
- 19Oral PresentationsPublic Health, Environmental and Occupational Health-72% vs groupOJR 0.45 → 0.12range -89% to -31%
- 20Arquivos Brasileiros de CardiologiaOACardiology and Cardiovascular Medicine-50% vs groupOJR 0.70 → 0.33range -64% to -30%
No-label zone, -9.1% to +10%Group median changeBar scale -92% to +1,100% (ratio scale)
Subfields of Medicine, compared.
- Surgery945
- Pulmonary and Respiratory Medicine352
- Public Health, Environmental and Occupational Health311
- Cardiology and Cardiovascular Medicine287
- Infectious Diseases258
- Oncology242
- Epidemiology178
- Neurology168
- Radiology, Nuclear Medicine and Imaging160
- Physiology154
- Endocrinology, Diabetes and Metabolism152
- Psychiatry and Mental health139
- Orthopedics and Sports Medicine121
- Ophthalmology96
- Pediatrics, Perinatology and Child Health95
- Dermatology89
- Obstetrics and Gynecology81
- Hematology78
- Rheumatology70
- Nephrology62
- Complementary and alternative medicine58
- Reproductive Medicine53
- Pharmacology49
- Emergency Medicine44
- Geriatrics and Gerontology38
- Otorhinolaryngology32
- Rehabilitation31
- Pathology and Forensic Medicine29
- Hepatology28
- Immunology and Allergy25
- Critical Care and Intensive Care Medicine24
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology13
- Health Informatics10
- Gastroenterology6
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
The endpoints below each rank show its likely range. How rank ranges are calculated
Citations made in 2025. Corpus-wide, 84.3% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
833 additional Medicine journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2022–2024, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2025. Publication window: 2022–2024. How these summaries are calculated
- Ranked journals
- 4,521
- Window papers (baseline)
- 2,982,923 +6.2% from indicator year 2022
- Median OJR
- 0.67 +2.0% from indicator year 2022
- Rising journals (2025)
- 404Comparison-group list (404)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2022–2024 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 1,634 | 1,746 | 1,853 | 1,933 | 2,023 | 2,148 | 2,258 | 2,390 | 2,497 | 2,616 | 2,755 | 2,949 | 3,131 | 3,412 | 3,611 | 3,760 | 3,936 | 4,122 | 4,350 | 4,487 | 4,543 | 4,639 | 4,671 | 4,692 | 4,640 | 4,521 | |
| Window papers (baseline) | 709,310 | 795,253 | 851,873 | 918,177 | 953,693 | 1,044,918 | 1,146,485 | 1,266,791 | 1,370,140 | 1,505,784 | 1,634,063 | 1,757,108 | 1,828,247 | 1,889,231 | 1,983,210 | 2,073,801 | 2,149,396 | 2,185,378 | 2,236,129 | 2,298,903 | 2,395,179 | 2,590,856 | 2,809,142 | 2,949,143 | 2,961,797 | 2,982,923 | |
| Median OJR | 0.48 | 0.53 | 0.56 | 0.60 | 0.61 | 0.63 | 0.68 | 0.704 | 0.724 | 0.739 | 0.756 | 0.748 | 0.760 | 0.730 | 0.749 | 0.741 | 0.725 | 0.717 | 0.701 | 0.702 | 0.715 | 0.663 | 0.655 | 0.661 | 0.660 | 0.67 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 3.2% | 3,512 journals |
| Retracted papers per 1,000 | Pooled rate: 1.465 per 1,000 | 3,472 journals |
| Output growth | Median: -6.9% | 4,166 journals |
| Open access share | Median: 100.0% | 4,521 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,046 | 2,526 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 20.0% | 4,393 journals |
| Review share | Median: 2.8% | 4,521 journals |
| Articles-only OJR | Median: 0.69 | 4,492 journals |
| Uncited share | Median: 37.6% | 4,521 journals |
| Citation concentration | Median: 46.3% | 4,514 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.